Oslo, 17 February 2022, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000 shares in the company at an average price of NOK 93.66 per share. Following this transaction, Carlos de Sousa and closely related parties hold 16,056 shares and 416,035 share options in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Attachment
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…
Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
Black Book Market Research issues a global operational alert alongside the release of its 2026…
The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…